Article Text

Download PDFPDF

Original research article
Distinct risk factors of atrial fibrillation in patients with and without coronary artery disease: a cross-sectional analysis of the BOREAS-CAG Registry data
  1. Naoto Murakami1,
  2. Masaya Tanno1,
  3. Nobuaki Kokubu1,
  4. Junichi Nishida1,
  5. Nobutaka Nagano1,
  6. Hirofumi Ohnishi2,
  7. Hiroshi Akasaka1,
  8. Takayuki Miki1,
  9. Kazufumi Tsuchihashi1,3 and
  10. Tetsuji Miura1
  1. 1Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
  2. 2Department of Public Health, Sapporo Medical University School of Medicine, Sapporo, Japan
  3. 3Division of Health Care Administration and Management, Sapporo Medical University School of Medicine, Sapporo, Japan
  1. Correspondence to Dr Masaya Tanno; tannom{at}sapmed.ac.jp

Abstract

Objective Although risk factors of atrial fibrillation (AF) in the general population have been characterised, their impacts on patients with specific diseases are unclear. Our aim was to determine whether risk factors of AF are different in patients with and those without coronary artery disease (CAD).

Methods We enrolled 1871 consecutive patients who underwent coronary angiography for evaluation of symptoms suggestive of CAD in the BOREAS-CAG Registry between August 2014 and January 2015. After exclusion of patients with valvular heart disease or a history of PCI/cardiac surgery, 1150 patients contributed to multivariate logistic regression analysis to identify risk factors of AF. We also retrieved data for 361 consecutive patients with CAD admitted to Sapporo Medical University Hospital between April 2013 and July 2014 and analysed data for 166 patients using the same inclusion and exclusion criteria as those in the BOREAS-CAG Registry.

Results Unexpectedly, CAD was independently associated with the absence of AF. The patients were then divided into a non-CAD group (n=576) and a CAD group (n=574) for further analysis. The brain natriuretic peptide level showed a strong association with AF regardless of the presence or absence of CAD. In the non-CAD group, lack of statin use was independently associated with AF, whereas high serum uric acid level was an independent explanatory variable of AF in the CAD group. The association of AF with uric acid was confirmed in a separate group of patients (n=166) enrolled in the CAD cohort in Sapporo Medical University Hospital.

Conclusions Major risk factors of AF are different in patients with CAD and those without CAD. Patients with CAD are more likely to develop AF when the serum uric acid level is high, whereas no statin administration predicts development of AF in patients without CAD.

  • CORONARY ARTERY DISEASE
  • uric acid
  • BOREAS-CAG Registry

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors NM and MT contribute to collection, analysis and interpretation of data and writing of manuscript. NK, JN and NN contribute to data collection and interpretation. HO, HA and TaM contribute to statistical support and data interpretation. KT contributes to conception and design of study. TeM contributes to conception and design of study, data analysis and writing of the manuscript.

  • Funding This study was supported by the Sapporo Medical University Education and Research Grants.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Ethics approval Clinical Investigation Ethics Committee of Sapporo Medical University Hospital.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement No additional data are available.